Mutlu Demiray

9PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapyHaematological tumoursExperimental methods in fluid flow, heat and mass transfer
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 14, 2024
Elacestrant plus alpelisib in an ESR1 and PIK3CA co-mutated and heavily pretreated metastatic breast cancer: the first case report for combination efficacy and safety.

Ünal Metin Tokat, Şevval Nur Bilgiç, Esranur Aydın

|Oct 25, 2024
Personalized Immunotherapy Achieves Complete Response in Metastatic Adenoid Cystic Carcinoma Despite Lack of Conventional Biomarkers.

Ünal Metin Tokat, Ashkan Adibi, Esranur Aydın

|Apr 22, 2024
Navigating uncharted territory: a case report and literature review on the remarkable response to personalized crizotinib containing combinational therapy in a pazopanib refractory patient with novel alterations.

Esranur Aydın, Ünal Metin Tokat, Eylül Özgü

|Dec 18, 2023
PARP inhibitor combinations with high-dose vitamin C in the treatment of Ewing sarcoma: two case reports and mechanistic overview.

Ashkan Adibi, Ünal Metin Tokat, Eylül Özgü

|Nov 05, 2020
Combinatorial Therapy of High Dose Vitamin C and PARP Inhibitors in DNA Repair Deficiency: A Series of 8 Patients.

Mutlu Demiray

|Apr 29, 2018
Management of extravasation of oxaliplatin by mimicking its biotransformation.

F Bahadori, M Demiray

Pageof 2

Frequent Collaborators

6 joint publications

Esranur Aydın

5 joint publications

Ashkan Adibi

5 joint publications

Eylül Özgü

4 joint publications

Ünal Metin Tokat